All Stories

  1. Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?
  2. The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling
  3. Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK
  4. La sobreexpresión vascular de la lisil oxidasa altera la estructura de la matriz extracelular e induce estrés oxidativo
  5. The nuclear receptor NOR-1 regulates vitronectin in human vascular smooth muscle cells
  6. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II–induced hypertrophy
  7. New genetic association for the kinin system: the L-arginine connection
  8. La inflamación inhibe la expresión vascular de la fibulina-5: implicación del factor de transcripción SOX9
  9. NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress
  10. Nestin+ cells direct inflammatory cell migration in atherosclerosis
  11. The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation
  12. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics
  13. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
  14. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats
  15. Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells
  16. miR-17 and -20a Target the Neuron-Derived Orphan Receptor-1 (NOR-1) in Vascular Endothelial Cells
  17. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells
  18. Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm
  19. miR-146a targets Fos expression in human cardiac cells
  20. CALU polymorphism A29809G affects calumenin availability involving vascular calcification
  21. The lysyl oxidase inhibitor  -aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats
  22. HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration
  23. NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation
  24. Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes
  25. Endothelial Krüppel-Like Factor 4 Modulates Pulmonary Arterial Hypertension
  26. El receptor nuclear NOR-1 regula la activación de las células vasculares y el remodelado vascular en respuesta a estrés hemodinámico
  27. Lysyl oxidase (LOX) in vascular remodelling
  28. Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm
  29. A major role for RCAN1 in atherosclerosis progression
  30. Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
  31. Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats
  32. Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation
  33. Over-expression of Neuron-derived Orphan Receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury
  34. Synergistic Effect of Thrombin and CD40 Ligand on Endothelial Matrix Metalloproteinase-10 Expression and Microparticle Generation In Vitro and In Vivo
  35. Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm
  36. Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients
  37. Imidazolineoxyl N-oxide induces COX-2 in endothelial cells role of free radicals
  38. Deficient p27 Phosphorylation at Serine 10 Increases Macrophage Foam Cell Formation and Aggravates Atherosclerosis Through a Proliferation-Independent Mechanism
  39. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions
  40. CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in Vascular Smooth Muscle Cells: Role of NF- B
  41. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia
  42. Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli
  43. Hypoxia upregulates PGI-synthase and increases PGI2release in human vascular cells exposed to inflammatory stimuli
  44. Emerging therapeutic strategies to enhance HDL function
  45. Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1α)-dependent Mechanism
  46. New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin
  47. Trans-10 cis-12-CLA dysregulate lipid and glucose metabolism and induce hepatic NR4A receptors
  48. Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation
  49. The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response of Endothelial Cells to Hypoxia
  50. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors
  51. p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats
  52. EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone
  53. Modulation of Endothelium and Endothelial Progenitor Cell Function by Low-Density Lipoproteins: Implication for Vascular Repair, Angiogenesis and Vasculogenesis
  54. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism
  55. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: Effect of simvastatin
  56. Retinoic acid induces PGI synthase expression in human endothelial cells
  57. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases
  58. Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction
  59. Thrombin and protease-activated receptors (PARs) in atherothrombosis
  60. Lysyl oxidase as a potential therapeutic target
  61. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli
  62. Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke
  63. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression
  64. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines
  65. Vascular effects of thrombin: Involvement of NOR-1 in thrombin-induced mitogenic stimulus in vascular cells
  66. Blood-Borne Tissue Factor Activity Predicts Major Cerebrovascular Events in Patients Undergoing Carotid Endarterectomy: Results from a 1-Year Follow-Up Study
  67. Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
  68. Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth
  69. Influence of Statin Use on Endothelial Function: From Bench to Clinics
  70. Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke
  71. Cell Biology and Lipoproteins in Atherosclerosis
  72. Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
  73. Efecto temprano de las estatinas después de un infarto de miocardio. ¿Se debe a los efectos pleiotrópicos?
  74. NOR-1 is involved in VEGF-induced endothelial cell growth
  75. Transcription Factor SOX18 Is Expressed in Human Coronary Atherosclerotic Lesions and Regulates DNA Synthesis and Vascular Cell Growth
  76. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation
  77. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells
  78. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells
  79. Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL
  80. Involvement of Neuron-Derived Orphan Receptor-1 (NOR-1) in LDL-Induced Mitogenic Stimulus in Vascular Smooth Muscle Cells: Role of CREB
  81. Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC
  82. Modulation of ERG25 expression by LDL in vascular cells
  83. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel–Palade bodies and in human endothelial cells
  84. Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation
  85. Neovascularización en arterias coronarias humanas con distintos grados de lesión
  86. Low Density Lipoproteins Downregulate Lysyl Oxidase in Vascular Endothelial Cells and the Arterial Wall
  87. Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor-Related Protein and LDL Receptors
  88. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels
  89. Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet-released products
  90. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
  91. 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLs : Balance Between Transcriptional and Posttranscriptional Regulation
  92. LDL Downregulates CYP51 in Porcine Vascular Endothelial Cells and in the Arterial Wall Through a Sterol Regulatory Element Binding Protein-2-Dependent Mechanism
  93. Biología celular y molecular de las lesiones ateroscleróticas
  94. LDL Receptor-Related Protein Mediates Uptake of Aggregated LDL in Human Vascular Smooth Muscle Cells
  95. Small oxidative changes in atherogenic LDL concentrations irreversibly regulate adhesiveness of human endothelial cells: effect of the lazaroid U74500A
  96. Reendotelización, engrosamiento intimal y remodelado vascular. ¿Un denominador común?
  97. Regulatory Effects of HDL on Smooth Muscle Cell Prostacyclin Release
  98. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition
  99. Esterified Cholesterol Accumulation Induced by Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells Is Reduced by HMG-CoA Reductase Inhibitors
  100. The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species
  101. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells
  102. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells
  103. HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
  104. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model
  105. Characterization of a cDNA Encoding a Cytosolic Peptidylprolyl Cis-Trans -Isomerase from Blattella Germanica
  106. Cytochrome c oxidase subunit I from the cockroach Blattella germanica: Cloning, developmental pattern and tissue expression
  107. 3-Hydroxy-3-methylglutaryl-coenzyme-A synthase from Blattella germanica. Cloning, expression, developmental pattern and tissue expression
  108. Molecular cloning, developmental pattern and tissue expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase of the cockroach Blattella germanica